Cargando…
Use of mesoporous polydopamine nanoparticles as a stable drug-release system alleviates inflammation in knee osteoarthritis
Osteoarthritis drugs are often short-acting; therefore, to enhance their efficacy, long-term, stable-release, drug-delivery systems are urgently needed. Mesoporous polydopamine (MPDA), a natural nanoparticle with excellent biocompatibility and a high loading capacity, synthesized via a self-aggregat...
Autores principales: | Wang, Yun, Ge, Weiwen, Ma, Zhigui, Ji, Guangyu, Wang, Mingsong, Zhou, Guangdong, Wang, Xiansong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIP Publishing LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033307/ https://www.ncbi.nlm.nih.gov/pubmed/35496642 http://dx.doi.org/10.1063/5.0088447 |
Ejemplares similares
-
The subacute toxicity and underlying mechanisms of biomimetic mesoporous polydopamine nanoparticles
por: Chen, Bang-Yao, et al.
Publicado: (2023) -
Inhaled curcumin mesoporous polydopamine nanoparticles against radiation pneumonitis
por: Chen, Ting, et al.
Publicado: (2022) -
Near-Infrared Light-Activated Mesoporous Polydopamine for Temporomandibular Joint Osteoarthritis Combined Photothermal-Chemo Therapy
por: Li, Qianli, et al.
Publicado: (2023) -
Mesoporous Silica Modified with Polydopamine and Zinc Ions as a Potential Carrier in the Controlled Release of Mercaptopurine
por: Sandomierski, Mariusz, et al.
Publicado: (2023) -
Study on combination therapy for lung cancer through pemetrexed‐loaded mesoporous polydopamine nanoparticles
por: Xu, Jian, et al.
Publicado: (2022)